We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
257 hedge funds and large institutions have $5.26B invested in Alnylam Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 93 increasing their positions, 89 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more call options, than puts
Call options by funds: $59.2M | Put options by funds: $43.1M
4% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 89
7% less funds holding
Funds holding: 277 → 257 (-20)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
32% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 53
33% less capital invested
Capital invested by funds: $7.86B → $5.26B (-$2.6B)
Holders
257
Holders Change
-20
Holders Change %
-7.22%
% of All Funds
7.18%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.22%
New
36
Increased
93
Reduced
89
Closed
53
Calls
$59.2M
Puts
$43.1M
Net Calls
+$16.1M
Net Calls Change
-$19.4M
Top Buyers
Top Sellers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$86M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$43.5M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$38.5M |
| 4 |
CCI
Columbus Circle Investors
|
-$28.5M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$21.2M |
